Company profile

Anumana, Inc.

Anumana, Inc. has 5 AI-enabled medical devices on the FDA list. The first decision was on September 28, 2023 and the most recent on June 15, 2026 (WatchMate Software). Its most common review panel is Cardiovascular (4 devices).

5AI devices
2023First decision
2026Latest decision
2Specialties

Per year

2023: 12025: 12026: 3
202320252026
Anumana, Inc. AI devices per year: 2023 1, 2025 1, 2026 3

By specialty

  • Cardiovascular4
  • Radiology1

Related guides

Top cardiovascular devices

Timeline

  1. WatchMate Software · Radiology · QIH
  2. ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040) · Cardiovascular · SHP
  3. ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020) · Cardiovascular · SAT
  4. ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) · Cardiovascular · QYE
  5. Low Ejection Fraction AI-ECG Algorithm · Cardiovascular · QYE